| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edgewise Therapeutics, Inc. (EWTX) has 15 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. EWTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 262.5K | $8.82M | - | |
| Other | 105.0K | $3.53M | - | |
| Dir | 45.1K | $1.52M | - | |
| CEO | 38.6K | $1.30M | - | |
| Dir | 30.0K | $1.01M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2021 | Novo Holdings A/s58 | 10% Owner | Buy | 625,000 | $16.00 | $10,000,000.00 | +12.6% | -23.8% | -70.3% | |
| Mar 30, 2021 | Root Jonathan D | Director | Buy | 15,625 | $16.00 | $250,000.00 | New | -23.8% | -70.3% |